Fetisov, T.I.; Borunova, A.A.; Antipova, A.S.; Antoshina, E.E.; Trukhanova, L.S.; Gorkova, T.G.; Zuevskaya, S.N.; Maslov, A.; Gurova, K.; Gudkov, A.;
et al. Targeting Features of Curaxin CBL0137 on Hematological Malignancies In Vitro and In Vivo. Biomedicines 2023, 11, 230.
https://doi.org/10.3390/biomedicines11010230
AMA Style
Fetisov TI, Borunova AA, Antipova AS, Antoshina EE, Trukhanova LS, Gorkova TG, Zuevskaya SN, Maslov A, Gurova K, Gudkov A,
et al. Targeting Features of Curaxin CBL0137 on Hematological Malignancies In Vitro and In Vivo. Biomedicines. 2023; 11(1):230.
https://doi.org/10.3390/biomedicines11010230
Chicago/Turabian Style
Fetisov, Timur I., Anna A. Borunova, Alina S. Antipova, Elena E. Antoshina, Lubov S. Trukhanova, Tatyana G. Gorkova, Svetlana N. Zuevskaya, Alexei Maslov, Katerina Gurova, Andrei Gudkov,
and et al. 2023. "Targeting Features of Curaxin CBL0137 on Hematological Malignancies In Vitro and In Vivo" Biomedicines 11, no. 1: 230.
https://doi.org/10.3390/biomedicines11010230
APA Style
Fetisov, T. I., Borunova, A. A., Antipova, A. S., Antoshina, E. E., Trukhanova, L. S., Gorkova, T. G., Zuevskaya, S. N., Maslov, A., Gurova, K., Gudkov, A., Lesovaya, E. A., Belitsky, G. A., Yakubovskaya, M. G., & Kirsanov, K. I.
(2023). Targeting Features of Curaxin CBL0137 on Hematological Malignancies In Vitro and In Vivo. Biomedicines, 11(1), 230.
https://doi.org/10.3390/biomedicines11010230